# ONWARD

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/onward

- Industry: Medical Devices & Equipment
- Headquarters: Eindhoven, Netherlands
- Website: www.onwd.com/
- Total disclosed funding: $28M
- Latest round: Series A (Jun 1, 2015)
- Investors on record: 4

## About

Based in Eindhoven, Netherlands, ONWARD, Inc., formerly known as GTX Medical, is a developer of therapies designed for recovery for people with spinal cord injuries.  The firm as of January 2024, is led by its CEO, Dave Marver.In October 2025, ONWARD, Inc. raised EUR 50.85 million in a private placement, selling 11.3 million shares at EUR 4.50 a piece on the Euronext FX.

ONWARD, Inc. therapies are designed to deliver targeted, programmed stimulation of the spinal cord via proprietary implantable or external systems, allowing caregivers to help restore movement and other functions in people with spinal cord injury. ONWARD, Inc. therapies are designed to deliver targeted, programmed stimulation of the spinal cord via proprietary implantable or external systems, allowing caregivers to help restore movement and other functions in people with spinal cord injury. Onward Inc generates revenue by providing digital engineering, ER&D, and IT services to global OEMs across mobility, industrial equipment, healthcare, and hi-tech sectors.

## Funding rounds

- Series A, Jun 1, 2015, $28M — Wellington Partners, EQT Life Sciences, Gimv, Inkef

## Investors

- Wellington Partners (https://capitalatlas.ai/funds/wellington-partners) — Series A
- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series A
- Gimv (https://capitalatlas.ai/funds/gimv) — Series A
- Inkef (https://capitalatlas.ai/funds/inkef) — Series A